Live feed/
Filings
/
SCHEDULE 13D/A
/
0001829126-26-011444
Stake: 7.33%
Shares: 11,250,000
CUSIP: 45339J105
Class: Common Stock, par value $0.01 per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE)
Conviction Score: 18/100
- Active Schedule 13D filer baseline
Item 4 — Purpose of Transaction
The information set forth in Item 4 in the Initial Schedule 13D is incorporated herein by reference. This Amendment No. 3 is being filed to report a decrease of more than 1% in the percentage of the outstanding Common Stock beneficially owned by the Reporting Person, resulting solely from the issuance of 20,338,974 shares of Common Stock in connection with the closing of the Issuer's private placement on October 16, 2026, as reported in the Issuer's Current Report on Form 8-K filed with the SEC on October 20, 2026. The Reporting Person did not acquire or dispose of any shares of Common Stock in connection therewith.
Cross-References
Insider Activity (last 365d)
16 transactions
11 buys · 5 sales · 0 awards/exercises
Issuer Cluster
12 13D/G filings on this issuer
11 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-09-30
DTC 1.03
822,250 shares short · -10.3% vs prior
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-03-23 |
Lazar David E. |
director |
Sale |
196,800 |
— |
— |
| 2026-03-23 |
Lazar David E. |
director |
Sale |
700,000 |
— |
— |
| 2026-02-26 |
Jabbour Jerome D |
director |
Award |
25,000 |
$2.06 |
$52K |
| 2026-02-11 |
Meckler Jeffrey A |
director, officer |
Disposition |
3,033 |
$47.60 |
$144K |
| 2026-02-11 |
Meckler Jeffrey A |
director, officer |
Award |
3,033 |
$1.75 |
$5K |
| 2026-02-11 |
Meckler Jeffrey A |
director, officer |
Disposition |
1,519 |
$29.40 |
$45K |
| 2026-02-11 |
Meckler Jeffrey A |
director, officer |
Award |
1,519 |
$1.75 |
$3K |
| 2026-02-11 |
Meckler Jeffrey A |
director, officer |
Disposition |
12,136 |
$8.30 |
$101K |
| 2026-02-11 |
Meckler Jeffrey A |
director, officer |
Award |
12,136 |
$1.75 |
$21K |
| 2026-01-20 |
Ben-Tzvi Avraham |
director |
Award |
25,000 |
— |
— |
| 2026-01-07 |
NATAN DAVID |
director |
Award |
25,000 |
$2.69 |
$67K |
| 2025-12-23 |
Ben-Tzvi Avraham |
director |
Award |
25,000 |
$1.95 |
$49K |
| 2025-12-22 |
Sassi Nir |
officer |
Award |
26,758 |
$2.03 |
$54K |
| 2025-12-22 |
Meckler Jeffrey A |
director, officer, 10%+ owner |
Award |
216,617 |
$2.03 |
$440K |
| 2025-12-22 |
Newman Michael James |
director, officer |
Award |
52,204 |
$2.03 |
$106K |
| 2025-12-22 |
Linscott Walt Addison |
officer |
Award |
54,421 |
$2.03 |
$110K |
Other 13D/G Filings on Indaptus Therapeutics, Inc.
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2026-10-22 |
SCHEDULE 13D/A |
Yao Yun |
27.34% |
41,991,000 |
view → |
| 2026-10-22 |
SCHEDULE 13D/A |
SINO LION VENTURES Ltd |
— |
38,895,000 |
view → |
| 2026-10-21 |
SCHEDULE 13D/A |
Yang Ting |
— |
9,948,173 |
view → |
| 2026-06-26 |
SCHEDULE 13D/A |
Yang Ting |
8.44% |
11,250,000 |
view → |
| 2026-06-26 |
SCHEDULE 13D/A |
Yao Yun |
31.51% |
41,991,000 |
view → |
| 2026-06-26 |
SCHEDULE 13D/A |
Dai Junyi |
8.44% |
11,250,000 |
view → |
| 2026-06-26 |
SCHEDULE 13D/A |
SINO LION VENTURES Ltd |
29.19% |
38,895,000 |
view → |
| 2021-11-17 |
SC |
Anderson Glen R. |
— |
— |
view → |
| 2021-10-26 |
SC |
Lee Hoonmo |
— |
— |
view → |
| 2021-10-26 |
SC |
Anderson Glen R. |
— |
— |
view → |
| 2021-10-26 |
SC |
Newman Michael James |
— |
— |
view → |
Other Filings by Dai Junyi
| Filed | Form | Issuer | Stake | Shares | |
|---|
| 2026-06-26 |
SCHEDULE 13D/A |
Indaptus Therapeutics, Inc. INDP |
8.44% |
11,250,000 |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →